1 Min Read
Feb 7 (Reuters) - Appili Therapeutics:
* APPILI THERAPEUTICS RAISES AN ADDITIONAL $4.3 MILLION IN OVERSUBSCRIBED FINANCING TO ADVANCE ITS ANTI-INFECTIVE PIPELINE Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.